-+ 0.00%
-+ 0.00%
-+ 0.00%

KYMERA THERAPEUTICS ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF KT-621 PHASE 1B DATA AT THE AMERICAN ACADEMY OF DERMATOLOGY (AAD) ANNUAL MEETING

Reuters·03/10/2026 11:00:01

Please log in to view news